Literature DB >> 6693198

Antigen expression in human melanoma cells in relation to growth conditions and cell-cycle distribution.

T Lindmo, C Davies, E K Rofstad, O Fodstad, A Sundan.   

Abstract

The expression of a melanoma-associated antigen, recognized by the monoclonal antibody 9.2.27, has been studied in the human FME melanoma cell line, grown as a monolayer under various conditions in vitro and as tumours in athymic mice. Two-parameter flow cytometric measurements of DNA and immunofluorescence showed that the antigen expression was uniform throughout the cell cycle. Highest expression of the melanoma-associated antigen was found in cultures in which the medium was frequently renewed (4 times in 6 days) and no contact inhibition was present. In comparison, the antigen expression of cells subjected to medium starvation (6 days without medium renewal) was reduced to 44%, and the cell size, as measured by forward angle light scatter, to 82% of the values found for optimally growing cells. Intermediate conditions, such as scanty medium supply or contact inhibition of growth, gave smaller effects. Two-parameter measurements of cell size and immunofluorescence demonstrated a positive correlation between cell size and antigen expression. The reduction in cell size, therefore, could explain part, but not all, of the reduction in antigen expression on medium-starved and contact-inhibited cells. The antigen expression on FME cells grown as xenografts in athymic mice varied between individual tumours and was lower than on cells from optimal in vitro growth. Due to smaller cell size, the antigen density was, however, comparable to that on cells from optimal in vitro growth.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693198     DOI: 10.1002/ijc.2910330203

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.

Authors:  S P Leong; P D Noguchi; R E Cunningham; T Takami; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice.

Authors:  H M Yang; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Immunohistochemical phenotyping of human solid tumors with monoclonal antibodies in devising biotherapeutic strategies.

Authors:  S K Liao; C Meranda; B P Avner; T Romano; S Husseini; B Kimbro; R K Oldham
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic treatment.

Authors:  C L Davies; T Ranheim; Z Malik; E K Rofstad; J Moan; T Lindmo
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.